(Q71718204)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

review article

1 reference

title

Pathophysiology of fibrinolysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Marie-Christine Alessi

1 reference

ORCID Public Data File 2021

author name string

Juhan-Vague I

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Alessi MC

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

Best Practice and Research: Clinical Haematology

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

329-343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

The alpha2-plasmin inhibitor levels in liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency *

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Comparison of the fibrinolytic response to 10 minutes venous occlusion in males with and without antecedent of deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Preoperative prediction of postoperative deep vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

The fibrinolytic system in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Pregnancy-induced changes in the fibrinolytic balance: evidence for defective release of tissue plasminogen activator and increased levels of the fast-acting tissue plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Urokinase Inhibitor in Human Placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Abnormal plasminogen, a case of recurrent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Mini-plasminogen like molecule in septic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Increased Fibrinolysis and Amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Homozygous protein C deficiency combined with heterozygous dysplasminogenemia found in a 21-year-old thrombophilic male

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Fibrinolysis and Hemorrhage in a Fatal Case of Heat Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Relationship between preoperative status of the fibrinolytic system and occurrence of deep vein thrombosis after major abdominal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Plasminogens Tochigi II and Nagoya: Two Additional Molecular Defects with Ala-600 → Thr Replacement Found in Plasmin Light Chain Variants123

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Phenformin and ethyloestrenol in recurrent venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

A critical review of the relationship between impaired fibrinolysis and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Prospective study of endogenous tissue plasminogen activator and risk of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Plasminogen Paris I: congenital abnormal plasminogen and its incidence in thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

A new type of congenital dysfibrinogenaemia with defective fibrin lysis--Dusard syndrome: possible relation to thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Release of vascular plasminogen activator (v-PA) after venous stasis: electrophoretic-zymographic analysis of free and complexed v-PA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Fibrinolysis in metastatic cancer of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

Intravascular Coagulation in Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980271-9

7 January 2021

10.1016/S0950-3536(05)80271-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7549066%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference